feed,title,long_url,short_url
SeekingAlpha,Sanofi puts brakes on phase 3 trials of myasthenia gravis candidate tolebrutinib,https://seekingalpha.com/news/3931991,
SeekingAlpha,Regal Rexnord's Broad-Based Business Model Is Really Getting It Done,https://seekingalpha.com/article/4575162,
